Literature DB >> 17126081

Mathematical modeling as accounting: predicting the fate of serum proteins and therapeutic monoclonal antibodies.

Brian Gurbaxani.   

Abstract

This article reviews current efforts to mathematically model the half lives of serum proteins, especially antibodies. While it is recognized that the neonatal Fc receptor, FcRn, is necessary for longer serum persistence of certain proteins, particularly the high abundance IgGs and albumin, it is not clear that it is sufficient to completely determine the half lives of these proteins. More specifically, it is unclear why the high avidity (bivalent), high affinity FcRn-IgG interaction, with half saturation in the 10 to 100 nM range (at endosomal pH according to the currently proposed mechanism), would result in a salvage mechanism that saturates at serum concentrations in the 10 to 100 mg/ml range--a discrepancy of 4 to 5 orders of magnitude. Alternative explanations include the proposal that the very low affinity binding between FcRn and IgG at blood pH is also relevant to the salvage mechanism, and that factors in addition to FcRn binding modulate the maintenance and clearance of IgG from serum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126081     DOI: 10.1016/j.clim.2006.10.001

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  3 in total

1.  Analytical FcRn affinity chromatography for functional characterization of monoclonal antibodies.

Authors:  Tilman Schlothauer; Petra Rueger; Jan Olaf Stracke; Hubert Hertenberger; Felix Fingas; Lothar Kling; Thomas Emrich; Georg Drabner; Stefan Seeber; Johannes Auer; Stefan Koch; Apollon Papadimitriou
Journal:  MAbs       Date:  2013-05-29       Impact factor: 5.857

2.  Computer-assembled cross-species/cross-modalities two-pore physiologically based pharmacokinetic model for biologics in mice and rats.

Authors:  Armin Sepp; Guy Meno-Tetang; Andrew Weber; Andrew Sanderson; Oliver Schon; Alienor Berges
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-05-11       Impact factor: 2.745

Review 3.  Pharmacokinetic models for FcRn-mediated IgG disposition.

Authors:  Jim J Xiao
Journal:  J Biomed Biotechnol       Date:  2012-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.